Correction

Article

Last month's edition of The BioPharm Bulletin contained an error in the article, "Promise and Challenges of Biotech Vaccines."

Last month’s edition of TheBioPharm Bulletin contained an error in the article, “Promise and Challenges of Biotech Vaccines.”  The 6th line from the end of the article should have read, “Deshmukh cited the example of the Prevnar vaccine, which requires a total of 14 or 15 separate processes, to make seven different polysaccharides and a carrier protein, and then seven conjugates.”

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Junevity Co-founder & CEO, John Hoekman, PhD
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.